Find all the latest Q2 results 2025 updates of Bharti Airtel, Titan Company, Power Grid Corporation of India, Ambuja Cements, ...
Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...
TBO Tek's results for the past two quarters show how global diversification can be a lifeline for online travel companies.
TG Therapeutics Inc (TGTX) reports a 93% revenue increase, driven by BRIUMVI sales, while navigating competitive challenges ...
Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes ...
Oklahoma’s 33–27 win over No. 14 Tennessee in Knoxville produced two conference award winners, as linebacker Owen Heinecke ...
Oklahoma’s 33–27 win over No. 14 Tennessee in Knoxville produced two conference award winners, as linebacker Owen Heinecke ...
The program seeks to empower trainees from tier I and tier II cities ... The top five teams from each sector will reach the final round, with cash prizes of INR 1,00,000, INR 75,000, and INR 50,000 ...
On the 4th, President Lee Jae-myung stated, "The government's budget proposal for next year is Korea's first budget to open ...
A Unit Linked Insurance Plan (ULIP) is a financial instrument that strategically combines essential life insurance coverage ...
13hon MSN
TG Therapeutics raises BRIUMVI 2025 revenue guidance to $585M while advancing subcutaneous pipeline
CFO Sean Power stated, "Our third quarter results reflect sustained commercial strength with total revenue reaching $161.7 million, an increase of 93% compared to Q3 '24 and 15% over Q2 '25. Product ...
Novo Nordisk continues to underperform the S&P 500, with a 42.5% YTD decline versus the index's 16.3% gain. Learn more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results